Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Analysis of Gastrointestinal Toxicity in Patients Receiving PBT for Prostate Cancer

08/08/2018
/ Publications
/
Toxicity

A study by the Seattle group. 192 prostate cancer patients were treated with PBT. With the median follow-up of 1.7 years, most of the observed GI toxicity (>90%...

Comparison of Grade 4 Lymphopenia With PT Vs Photon Therapy for Esophageal Cancer.

01/01/2019
/ Publications
/
Survival

Grade 4 lymphopenia (G4L) during radiation therapy (RT) is associated with higher rates of distant metastasis and decreased overall survival. 79 patients...

Proton Therapy for Prostate Cancer

11/09/2018
/ Publications
/
Dosimetry
Clinical Trial

A review examined the dosimetric rationale and theoretical benefit of proton radiation for prostate cancer and the current state of the clinical evidence for...

Effectiveness of Particle Radiotherapy in Various Stages of HCC

11/03/2018
/ Publications
/
Survival

A retrospective report from Japan. Eighty-three patients with HCC underwent particle therapy including proton beam radiation in 58 patients and carbon ion...

Proton beam therapy for gastrointestinal cancers

11/10/2018
/ Publications

A review on recent data that PBT for upper GI cancers may decrease acute toxicity and late complications and improve treatment compliance.

The authors examined...

Current and emerging radiotherapy strategies for pancreatic adenocarcinoma.

08/08/2018
/ Publications
/
IMRT

A review article by MD Anderson examined the available outcome data of IMRT, SBRT and proton and carbon ion therapy for locally advanced pancreatic cancer, and...

Initial experience with IMPT for intact, clinically localized pancreas cancer.

08/04/2018
/ Publications
/
IMPT
Chemotherapy

A Mayo Clinic study reported outcomes of IMPT for intact and clinically localized pancreatic cancer. 13 patients with localized pancreatic cancer underwent...

Initial toxicity, QoL outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated vs. standard fractionated PT for low-risk prostate cancer

08/02/2018
/ Publications
/
Hypofractionation
Quality of life

A multi-center prospective phase 3 randomized trial aimed to identify differences in toxicity and quality-of-life outcomes between standard fractionation and...

Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes.

08/09/2018
/ Publications
/
Quality of life

A study by the Seattle group analyzed 231 patients of localized prostate cancer treated with protons. Median follow-up was 1.7 years. Grade 3 toxicity was seen...

Initial report of the genitourinary and gastrointestinal toxicity of post-prostatectomy proton therapy for prostate cancer patients undergoing adjuvant or salvage radiotherapy.

08/07/2018
/ Publications
/
Toxicity

A retrospective analysis on 100 patients' acute and late genitourinary (GU) and gastrointestinal (GI) toxicities associated with post-prostatectomy proton...